Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Profound Matrix
Locations
2
United States
Candela Institue for Excellence
Marlborough, Massachusetts, United States
Syneron Medical
Yokneam Illit, Israel
Start Date
October 29, 2023
Primary Completion Date
December 29, 2023
Completion Date
July 1, 2024
Last Updated
October 8, 2024
NCT07495865
NCT07187297
NCT07255261
NCT07222397
NCT06074276
NCT05987319
Lead Sponsor
Candela Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions